Title: O'Neill BT, et al. Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking Hypopigmentation. J Med Chem. 2018 May 24;61(10):4476-4504.
1821-52-9 | Dl-indole-3-lactic acid | AA0023B6 | MFCD00005642
182410-00-0 | Sodium sulphobutylether-beta-cyclodextrin | AA0023SC | MFCD12032209
18282-40-1 | 2-Ethyliodobenzene | AA00243I | MFCD00040871
176251-49-3 | 8,8-Difluoro-1,4-dioxaspiro[4.5]decane | AA0024GO | MFCD11847478
17672-21-8 | Methyl 2-amino-3-hydroxybenzoate | AA0024SF | MFCD01675233
177171-16-3 | 3-Trimethylsilylphenylboronic acid | AA00252C | MFCD03093884
17763-78-9 | Methanesulfonic acid, 1,1,1-trifluoro-, [1,1'-biphenyl]-4-yl ester | AA0025CW | MFCD18379753
177991-01-4 | Benzene, 1,1',1'',1'''-methanetetrayltetrakis[4-ethynyl- | AA0025M7 | MFCD24873189
31244-41-4 | 1-Butanol, 4-(ethenyloxy)-, homopolymer | AA01X389 | MFCD00080697
17873-01-7 | P-Tolyltrimethoxysilane | AA002679 | MFCD00048020